Don't miss an opportunity to hear this new presentation by Dr. Rossignol for parents already familiar with biomedical interventions used in autism. This is our seventh presentation in our "Advanced Biomedical Education" series.

Saturday, January 28th, 2012

Hyperbaric Oxygen Therapy for Neurological Conditions

Saturday, January 28th • 6:30 pm - 8:30 pm • Irvine, California

HBOT research outcomes are very promising for various conditions such as Autism, CP, Stroke, MS, Mitochondrial Disease, Chronic Fatigue, Lyme Disease and other neurological conditions. Dr. Rossignol, along with patients who are winning the battle with these conditions will discuss this critical therapy.

Dan Rossignol MD FAAFP 

To see the latest published studies by Dr. Rossignol, visit

Co-author/author of Mitochondrial Dysfunction in Autism Spectrum Disorders, Folate Autism Receptor Autoimmunity in Autism Spectrum Disorders.

Dr. Rossignol received his Doctorate of Medicine at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. He is currently a physician at ICDRC in Melbourne, FL.

Coming from an academic background, Dr. Rossignol searched the medical literature looking for a solution after both of his children were diagnosed with autism. Finding no obvious solution, he made it his mission to research and publish in autism. In the last 5 years, he has published 8 papers as the lead author for a total of 15 papers on autism with 5 more to be published this year. He has also written 3 book chapters on autism.

Dr Rossignol received the prestigious Edgar End Memorial Award from the Undersea Hyperbaric Medical Society for his pioneering paper in hyperbaric research in autism.

No Cost to Attend
Limited Seating
RSVP by calling (888) 278-4268

16251 Laguna Canyon Road, #175
Irvine, CA 96251

For more information please visit:

You received this email because you expressed an interest in receiving information about workshops being offered at this clinic. To be removed from this mailing list, please click here.

For more information please visit: